Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Haematologica|April 11, 2000
Amifostine in the treatment of low-risk myelodysplastic syndromesA Grossi, A Fabbri, V Santini, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 1998
Diaminic carbonates, a new class of anti-inflammatory compounds: their biological characterization and mode of actionG Porro, G Bertolini, M A Bonardi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1989
Idiotypic replica of an anti-human tumor-associated antigen monoclonal antibody. Analysis of monoclonal Ab1 and Ab3 fine specificityG Viale, G Flamini, F Grassi, et al.
Cancer|November 26, 1999
Fludarabine, cytarabine, and granulocyte-colony stimulating factor for the treatment of high risk myelodysplastic syndromesF Ferrara, F Leoni, A Pinto, et al.
International Journal of Cancer|May 8, 1992
Glycolipids carrying Le(y) are preferentially expressed on small-cell lung cancer cells as detected by the monoclonal antibody MLuC1F Leoni, M I Colnaghi, S Canevari, et al.
The Cancer Journal From Scientific American|February 11, 1998
Interleukin-2 therapy in relapsed acute myelogenous leukemiaG Meloni, M Vignetti, E Pogliani, et al.
Tumori|December 31, 1990
Expression of two antigens defined by monoclonal antibodies in normal, benign and malignant human mammary tissuesF Perrone, S Ménard, M G Da Dalt, et al.
British Journal of Haematology|April 1, 1991
Long-term outcome of adults with acute myelogenous leukaemia: results of a prospective, randomized study of chemotherapy with a minimal follow-up of 7 yearsG Bandini, E Zuffa, G Rosti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1991
Evaluation of resection margins after breast conservative surgery with monoclonal antibodiesU Veronesi, G Farante, V Galimberti, et al.
The International Journal of Biological Markers|October 1, 1989
Detection of Lewis(a) antigen in sera of ovarian carcinoma patients by MOv2-MOv8 double-determinant radioimmunoassayL Mantovani, V Azzini, S Canevari, et al.
Pageof 10